Cutaneous intravascular natural killer/T cell lymphoma with peculiar immunophenotype
Authors:
- 2 August 2017
- journal article
- case report
- Published by Wiley in Histopathology
- Vol. 71 (6) , 994-1002
Abstract
Intravascular lymphoma (IVL) is a rare entity. Most cases are a variant of extranodal diffuse large B cell lymphoma, and fewer than 10% of the published cases are of T cell origin. Only intravascular B cell lymphoma is recognized as a distinct entity in the most recent World Health Organization (WHO) classification of lymphoproliferative disorders. We describe a case of cutaneous natural killer (NK)/T IVL, with a cytotoxic immunophenotype and Epstein–Barr virus (EBV) positivity. However, our case was immunohistochemically negative not only for T cell receptor (TCR)‐βF1 and TCR‐γ (TCR‐silent), but also for CD56, making it the first triple‐negative NK/T IVL case to be described. We urge recognition of this NK/T cell lineage intravascular lymphoma due to its particular immunophenotypical profile and its unvarying relationship with EBV. Its occurrence should not be considered a coincidence, but rather a key aspect of the pathogenic background of this haematological neoplasm.Keywords
This publication has 35 references indexed in Scilit:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a ReassessmentCurrent Hematologic Malignancy Reports, 2015
- The Epstein–Barr virus and the pathogenesis of lymphomaThe Journal of Pathology, 2014
- Intravascular Large B-Cell LymphomaArchives of Pathology & Laboratory Medicine, 2012
- Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus MeetingJournal of Clinical Oncology, 2007
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Malignant angioendotheliomatosis: An angiotropic lymphomaJournal of the American Academy of Dermatology, 1989
- Further Evidence That Malignant Angioendotheliomatosis Is an Angiotropic Large-Cell LymphomaNew England Journal of Medicine, 1986
- Neoplastic Angioendotheliomatosis: Immunopathologic and Morphologic Evidence for Intravascular Malignant LymphomatosisAmerican Journal of Clinical Pathology, 1986
- Malignant Angioendotheliomatosis: An Angiotropic Lymphoma?American Journal of Clinical Pathology, 1985